NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with Irish Pharmacist includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

ADVERTISMENT

ADVERTISMENT

Researchers Develop 3d Treatment That Could Revolutionise Diabetes Care

By Irish Pharmacist - 01st Nov 2022

Diabetes

Researchers at Queen’s University Belfast have designed a new bandage treatment, known as a scaffold, to treat diabetic foot ulcers (DFUs), which is cost-effective while improving patient outcomes. Produced by 3D bioprinting, the scaffolds slowly release antibiotics over a four-week period to effectively treat the wound. 

Diabetes, a life-long condition that causes a person’s blood sugar level to become too high, is among the top-10 causes of deaths worldwide. 

DFU is a serious complication of diabetes, affecting approximately 25 per cent of diabetic patients. When identified, over 50 per cent are already infected and over 70 per cent of cases result in lower-limb amputation. 

The treatment strategy required for the effective healing of DFU is a complex process that requires several combined therapeutic approaches. As a result, there is a significant clinical and economic burden associated in treating DFU. These treatments are often unsuccessful, which leads to lower-limb amputation. 

This new research demonstrates outcomes with significant implications for patient quality of life, as well as decreasing the costs and clinical burden in treating DFU. 

Recent research has focused on drug-loaded scaffolds to treat DFU. The scaffold structure is a novel carrier for cell and drug delivery that enhances wound-healing. 

The research, published in Springer Link, was presented by Prof Dimitrios Lamprou, Professor of Biofabrication and Advanced Manufacturing at Queen’s School of Pharmacy and corresponding author, at the Controlled Release Society (CRS) Workshop, Italy, on 7-9 October. 

“These scaffolds are like windows that enable doctors to monitor the healing constantly. This avoids needing to remove them constantly, which can provoke infection and delay the healing process,” he commented. 

“The ‘frame’ has an antibiotic that helps to ‘kill’ the bacteria infection, and the ‘glass’ that can be prepared by collagen/sodium alginate can contain a growth factor to encourage cell growth. The scaffold has two molecular layers that both play an important role in healing the wound.” 

Lead author Ms Katie Glover from the Queen’s School of Pharmacy added: “Using bioprinting technology, we have developed a scaffold with suitable mechanical properties to treat the wound, which can be easily modified to the size of the wound. This provides a low-cost alternative to current DFU treatments, which could revolutionise DFU treatment, improving patient outcomes while reducing the economic burden caused by rapidly-increasing patient demand as the number of people with diabetes continues to increase every year.” 

ADVERTISMENT

Latest

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

Latest Issue

Irish Pharmacist October 2024

Read

OTC Autumn 2024

In this issue of OTC Update we focus on hydration, hair care, sports injuries, fatigue, and menopause.??

Read

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT